|
Melatonin: therapeutic and clinical utilization
|
17 March 2024 |
|
Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin
|
11 February 2024 |
|
Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type
|
06 January 2024 |
|
Mechanism for the antitumor and anticachectic effects of n-3 fatty acids
|
30 December 2023 |
|
Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage
|
28 December 2023 |
|
Actions of melatonin in the reduction of oxidative stress. A review
|
24 December 2023 |
|
Melatonin as Antioxidant Under Pathological Processes
|
08 December 2023 |
|
Melatonin attenuates estradiol-induced oxidative damage to DNA: relevance for cancer prevention
|
19 November 2023 |
|
Resolution of thymoma-related pure red cell aplasia after octreotide treatment
|
02 September 2023 |
|
Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers
|
20 June 2023 |